Clinical Trial Update: Secretin Enhanced MRCP for Evaluation of Pancreatic Duct in Pediatric Population [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating Secretin Enhanced MRCP to evaluate the pancreatic duct in pediatric patients with acute recurrent pancreatitis or chronic pancreatiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatitis

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Acute Recurrent Pancreatitis, Chronic Pancreatitis | Phase 1 | Status: TERMINATED